C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Weighing Risks
An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension’s effect on global needs for a one-shot, easy-to-ship vaccine.
View original article
Contributor: Denise Grady and Carl Zimmer
